Voydeya 50 mg / 100 mg, Filmtabletten

7680693010031 CH-69301 Filmtabletten

Associated product:

VOYDEYA 50 mg / 100 mg cpr pellic 50 mg 180(2x90)

No image available

Article details

Package size
180 (2x90)
Selling units
16200
Measure
Tablette(n)
Galenic form
Filmtabletten
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
05/04/2026
Summary of Product Characteristics
Français
05/04/2026
Summary of Product Characteristics
Italien
05/04/2026
Patient information leaflet
Allemand
17/03/2025
Patient information leaflet
Français
17/03/2025
Patient information leaflet
Italien
17/03/2025

Detailed composition

Substance Quantity Type Category
danicopanum
50.0 MG Substance Wirkstoff (Principe actif)
danicopanum
100.0 MG Substance Wirkstoff (Principe actif)
hypromellosi acetas succinas
- Substance HNIDK
hypromellosi acetas succinas
- Substance HNIDK
lactosum monohydricum
121.0 MG Substance HBESI
lactosum monohydricum
60.5 MG Substance HBESI
cellulosum microcristallinum
- Substance HNIDK
cellulosum microcristallinum
- Substance HNIDK
carmellosum natricum conexum
- Substance HNIDK
carmellosum natricum conexum
- Substance HNIDK
natrii laurilsulfas
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
natrii laurilsulfas
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
silica colloidalis anhydrica
- Substance HNIDK
silica colloidalis anhydrica
- Substance HNIDK
magnesii stearas
- Substance HNIDK
magnesii stearas
- Substance HNIDK
poly(alcohol vinylicus)
- Substance HNIDK
poly(alcohol vinylicus)
- Substance HNIDK
E 171
- Substance FNIDK
E 171
- Substance FNIDK
macrogolum 3350
- Substance HNIDK
macrogolum 3350
- Substance HNIDK
talcum
- Substance HNIDK
talcum
- Substance HNIDK
natrium
- Substance HBESI
natrium
- Substance HBESI

Authorization holder

Alexion Pharma GmbH

6340 Baar

Authorization information

Swissmedic authorization number
69301
Drug name
Voydeya, Filmtabletten
Galenic form
FILM
ATC Code
L04AJ09
Authorization status
Z
Dispensing category
A
First authorization
30/04/2024
Authorization expiration date
29/04/2029
IT Number
07.15.0.
Domain
Human medicine
Field of application
als Zusatztherapie zu Ravulizumab oder Eculizumab zur Behandlung bei klinisch relevanter extravaskulärer Hämolyse nach mindestens 6-monatiger Monotherapie mit einem C5-Inhibitor bei erwachsenen Patienten mit paroxysmaler nächtlicher Hämoglobinurie

Package details

Description (FR)
VOYDEYA 50 mg / 100 mg cpr pellic 50 mg 180(2x90)
Description (DE)
VOYDEYA 50 mg / 100 mg Filmtabl 50 mg 180(2x90) St
Market launch
30/04/2024
Narcotic (BTM)
No

Other package sizes (3)

None
168 TABL
GTIN: None
Not in V1
None
168 (4x42) TABL
GTIN: None
Not in V1
VOYDEYA cpr pellic 100 mg 180(2x90) pce
180 (2x90) TABL
GTIN: 7680693010048
View
Buy us a coffee Explore the data